The core activity of EarlySight SA is the development and manufacture of medical devices and technologies for ophthalmology, particularly for the diagnosis and treatment of eye diseases. The company focuses on developing precise eye imaging and analysis technologies that enable the visualization and analysis of the retinal pigment epithelium (RPE) layer. These technologies aim to enable earlier diagnosis and treatment of eye diseases, thereby improving the quality of life for patients.